NOBEL BIOCARE DANMARK A/S: Financial statements 2020
CVR: 28293364
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 4,787,016 and a net result of DKK -793,925 compared with DKK -5,470,814 the year before. That is an increase of 21.2% compared with the year before. Equity in the 2020 report amounted to DKK -1,409,588. The company had 5 employees in the financial year.
- Gross Profit
- DKK 4,787,016
- Profit/Loss
- DKK -793,925
- Equity
- DKK -1,409,588
- Total Assets
- DKK 121,201,916
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 4.8M | -794K | -1.4M | 5 |
| 2019 | - | 4M | -5.5M | -616K | 4 |
| 2018 | - | 3.3M | 420K | 4.9M | 3 |
| 2017 | - | 3.8M | 580K | 4.4M | 4 |
| 2016 | - | 6.3M | 894K | 3.9M | 4 |
Official annual report
How creditworthy is NOBEL BIOCARE DANMARK A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 11, 2020, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of NOBEL BIOCARE DANMARK A/S.
As of December 11, 2020, EY Godkendt Revisionspartnerselskab has stepped down as auditor of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2019. Gross profit came to DKK 3,951,270, and the net result was DKK -5,470,814.
As of June 8, 2020, Lars Fredrik Strömberg has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 8, 2020, Hans Braunstein has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 8, 2020, Lars Fredrik Strömberg is registered as director of NOBEL BIOCARE DANMARK A/S.
As of June 8, 2020, Hans Braunstein has stepped down as director of NOBEL BIOCARE DANMARK A/S.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.